Cummins Inc. Share Price Target ‘$302.37’, now 5.9% Upside Potential

DirectorsTalk Interviews

Cummins Inc. which can be found using ticker (CMI) now have 16 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The target price High/Low ranges between $345.00 and $259.00 calculating the mean target share price we have $302.37. (at the time of writing). Now with the previous closing price of $285.56 and the analysts are correct then there would likely be a percentage uptick in value of 5.9%. The day 50 moving average is $289.40 and the 200 day MA is $249.53. The market capitalization for the company is 38.96B. The stock price for the company is currently $284.84 USD

The potential market cap would be $41,253,889,196 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 20.88, revenue per share of $240.13 and a 6.6% return on assets.

Cummins Inc. offers complementary business segments that design, manufacture, distribute and service a portfolio of power solutions. The Company’s segments include Components, Engine, Distribution, Power Systems, and Accelera. The Components segment sells filtration products, aftertreatment systems, turbochargers, electronics, fuel systems, automated transmissions, axles, and suspension systems. The Engine segment produces engines and associated parts for sale to customers in on-highway and various off-highway markets. The Distribution segment includes distributorships engaged in wholesaling engines, generator sets and service parts. The Power Systems segment is an integrated power provider, which designs, manufactures, and sells engines for industrial applications, standby and prime power generator sets, alternators, and other power components. The Accelera segment designs, manufactures, sells and supports hydrogen production solutions as well as electrified power systems.

Share on:

Latest Company News

Genflow Biosciences reports early findings from SIRT6 gene therapy study

Genflow Biosciences reports early findings from its SIRT6 gene therapy study in older dogs, with further monitoring planned over...

Ilika CEO to discuss battery gigafactory development at Barcelona industry forum

Ilika CEO Graeme Purdy is set to speak at the December 2026 Barcelona battery gigafactory forum, bringing the company's...

Investors demand clear returns as AI spending comes under scrutiny

Investors are demanding clearer returns from AI spending as technology shares face pressure, with corporate earnings, data centre investment...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

itim Group targets retail AI market with new platform launch

ITIM Group is targeting the retail AI market with itimAIQ, a new platform designed to automate operations, improve efficiency...

Drax sets date for 2026 Capital Markets Day and trading update

Drax Group will host its Capital Markets Day on 23 November 2026, providing investors and analysts with a management...

    Search